“lupus” Archives

Entry Author Date Location
Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights 07/24/17 Indiana
Corbus Shares Climb on Early Data For Inflammation Drug 11/14/16 Boston
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases 09/14/16 Boston
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
NY Bio Startup Syntimmune Gets $10M From Baxalta, Apple Tree 03/22/16 New York
West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More 05/22/15 San Diego
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitions 03/12/15 San Francisco
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Houston’s Capital Royalty Evolving in Healthcare Growth Financing 11/19/13 Texas
UW Spinoff Resolve Therapeutics Snags $5.8M for Lupus Drug 11/01/12 Seattle
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets 10/12/11 New York
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
The New Normal for Biotech Startups 01/26/11 Seattle
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners 12/15/10 Boston
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
La Jolla Pharmaceutical Revives With $6M Financing 05/26/10 San Diego
La Jolla Pharmaceutical: Going, Going, But Not Quite Gone 02/26/10 San Diego
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Zymo Drug Fails Arthritis Trials 09/10/09 Seattle
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News 07/23/09 Seattle
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug 07/21/09 Seattle
La Jolla Pharmaceutical Gets Delisting Notice 04/09/09 San Diego
Biogen Idec, Extending Life of its Top-Selling Drug, Eyes Longer-Lasting Shot for MS 03/27/09 Boston
Trubion Starts Lupus Trial 03/25/09 Seattle
Biogen Idec, Genentech’s Rituxan Fails in Pivotal Study of Lupus of Kidneys 03/11/09 Boston
Cypress Buys Lupus Test 02/24/09 San Diego
Page 1 of 2 next page »